Literature DB >> 18948034

Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery.

Stefano Salis1, Valeria V Mazzanti, Guido Merli, Luca Salvi, Calogero C Tedesco, Fabrizio Veglia, Erminio Sisillo.   

Abstract

OBJECTIVE: The aim of this study was to determine if there is a direct relationship between the duration of cardiopulmonary bypass (CPB time [CPBT]) and postoperative morbidity and mortality in patients undergoing cardiac surgery.
DESIGN: Retrospective study.
SETTING: Cardiac surgery unit, university hospital. PARTICIPANTS: Five thousand six patients, New York Heart Association classes 1 through 4, who underwent cardiac surgery between January 2002 and March 2008.
INTERVENTIONS: All patients were subjected to CPB.
MEASUREMENTS AND MAIN RESULTS: The mean CPBT was 115 minutes (median 106). One hundred thirty-one patients (2.6%) died during the same hospitalization. The postoperative median blood loss was 600 mL. Reoperations for bleeding occurred in 193 patients (3.9%), and 1,001 patients received 3 or more units of red blood cells. There were 108 patients (2.2%) with neurologic sequelae, 391 patients (7.8%) with renal complications, 37 patients (0.7%) with abdominal complications, and 184 patients (3.7%) with respiratory complications. Seventy-two patients (1.4%) had an infective complication, and 80 patients (1.6%) had a postoperative multiorgan failure. The multivariate analysis confirmed the role of CPBT, considered in 30-minute increments, as an independent risk factor for postoperative death (odds ratio [OR] = 1.57, p < 0.0001), pulmonary (OR = 1.17, p < 0.0001), renal (OR 1.31, p < 0.0001), and neurologic complications (OR = 1.28, p < 0.0001), multiorgan failure (OR = 1.21, p < 0.0001), reoperation for bleeding (OR = 1.1, p = 0.0165), and multiple blood transfusions (OR = 1.58, p < 0.0001).
CONCLUSIONS: Prolonged CPB duration independently predicts postoperative morbidity and mortality after cardiac surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18948034     DOI: 10.1053/j.jvca.2008.08.004

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  72 in total

1.  Report from AmSECT's International Consortium for Evidence- Based Perfusion Consensus Statement: Minimal Criteria for Reporting Cardiopulmonary Bypass-Related Contributions to Red Blood Cell Transfusions Associated With Adult Cardiac Surgery.

Authors:  Donald S Likosky; Robert A Baker; Timothy A Dickinson; Daniel J FitzGerald; M Filip De Somer; Robert C Groom; David FitzGerald; Kenneth G Shann; Michael Poullis; Bruce D Spiess; Karim Jabr; Mark T Lucas; James D Ferguson; Shahna L Bronson
Journal:  J Extra Corpor Technol       Date:  2015-06

Review 2.  Sutureless aortic valve replacement.

Authors:  Marco Di Eusanio; Kevin Phan
Journal:  Ann Cardiothorac Surg       Date:  2015-03

Review 3.  Sutureless aortic valve replacement: a systematic review and meta-analysis.

Authors:  Kevin Phan; Yi-Chin Tsai; Nithya Niranjan; Denis Bouchard; Thierry P Carrel; Otto E Dapunt; Harald C Eichstaedt; Theodor Fischlein; Borut Gersak; Mattia Glauber; Axel Haverich; Martin Misfeld; Peter J Oberwalder; Giuseppe Santarpino; Malakh Lal Shrestha; Marco Solinas; Marco Vola; Tristan D Yan; Marco Di Eusanio
Journal:  Ann Cardiothorac Surg       Date:  2015-03

4.  Use of an automated knot fastener shortens operative times in minimally invasive mitral valve repair.

Authors:  G Perin; M Shaw; V Pingle; K Palmer; O Al-Rawi; T Ridgway; D Pousios; P Modi
Journal:  Ann R Coll Surg Engl       Date:  2019-06-03       Impact factor: 1.891

5.  The importance of coronary artery disease and special considerations for left ventricular assist device implantation.

Authors:  Mevlüt Çelik; John M Stulak; Simon Maltais
Journal:  Ann Cardiothorac Surg       Date:  2021-03

6.  Staged percutaneous coronary intervention followed by minimally invasive mitral valve surgery versus combined coronary artery bypass graft and mitral valve surgery for two-vessel coronary artery disease and moderate to severe ischemic mitral regurgitation.

Authors:  Christos G Mihos; Steve Xydas; Roy F Williams; Andrés M Pineda; Evin Yucel; Hector Davila; Nirat Beohar; Orlando Santana
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

7.  Minimally invasive aortic valve replacement-where are we?

Authors:  Sameer Arora; John P Vavalle
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

Review 8.  Current strategies for spinal cord protection during thoracic and thoracoabdominal aortic aneurysm repair.

Authors:  Hideyuki Shimizu; Ryohei Yozu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-03-30

9.  Reduced Left Ventricular Global Longitudinal Strain Predicts Prolonged Hospitalization: A Cohort Analysis of Patients Having Aortic Valve Replacement Surgery.

Authors:  Abraham Sonny; Andrej Alfirevic; Shiva Sale; Nicole M Zimmerman; Jing You; A Marc Gillinov; Daniel I Sessler; Andra E Duncan
Journal:  Anesth Analg       Date:  2018-05       Impact factor: 5.108

10.  Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model.

Authors:  F Kaspereit; S Hoffmann; I Pragst; G Dickneite
Journal:  Br J Anaesth       Date:  2010-08-17       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.